1. Systemic phenotype related to primary Sjogren's syndrome in 279 patients carrying isolated anti-La/SSB antibodies
- Author
-
Acar-Denizli, Nihan, Horváth, Ildiko-Fanny, Mandl, Thomas, Priori, Roberta, Vissink, Arjan, Hernandez-Molina, Gabriela, Armagan, Berkan, Praprotnik, Sonja, Sebastian, Agata, Bartoloni, Elena, Rischmueller, Maureen, Pasoto, Sandra G, Nordmark, Gunnel, Nakamura, Hideki, Fernandes Moça Trevisani, Virginia, Retamozo, Soledad, Carsons, Steven E, Maure-Noia, Brenda, Sánchez-Berná, Isabel, López-Dupla, Miguel, Fonseca-Aizpuru, Eva, Melchor Díaz, Sheila, Vázquez, Marcos, Díaz Cuiza, P Ericka, de Miguel Campo, Borja, Ng, Wan-Fai, Rasmussen, Astrid, Dong, Xu, Li, Xiaomei, Baldini, Chiara, Seror, Raphaele, Gottenberg, Jacques-Eric, Kruize, Aike A, Sandhya, Pulukool, Gandolfo, Saviana, Kwok, Seung-Ki, Kvarnstrom, Marika, Solans, Roser, Sene, Damien, Suzuki, Yasunori, Isenberg, David A, Valim, Valeria, Hofauer, Benedikt, Giacomelli, Roberto, Devauchelle-Pensec, Valerie, Atzeni, Fabiola, Gheita, Tamer A, Morel, Jacques, Izzo, Raffaella, Bootsma, Hendrika, Personalized Healthcare Technology (PHT), and Translational Immunology Groningen (TRIGR)
- Subjects
musculoskeletal diseases ,anti-Ro/SSA antibodies ,primary Sjogren's syndrome ,systemic disease ,DIAGNOSIS ,Cohort Studies ,stomatognathic system ,big data ,LYMPHOMA ,Humans ,isolated La/SSB auto-antibodies ,CLASSIFICATION CRITERIA ,Registries ,DISEASE-ACTIVITY INDEX ,IDENTIFICATION ,eye diseases ,Sjogren's Syndrome/diagnosis ,stomatognathic diseases ,Phenotype ,MANIFESTATIONS ,LOWER PREVALENCE ,Female ,AUTOANTIBODIES ,LA ,CONSENSUS ,ESSDAI - Abstract
Objective. To evaluate the systemic phenotype associated with the presence of isolated anti-La/SSB antibodies in a large international registry of patients with primary Sjogren's syndrome (pSS) fulfilling the 2002 classification criteria. Methods. The Big Data Sjogren Project Consortium is an international, multicentre registry created in 2014. Baseline clinical information from leading centres on clinical research in SS of the 5 continents was collected. Combination patterns of anti-Ro/SSA-La/SSB antibodies at the time of diagnosis defined the following four immunological phenotypes: double positive (combined Ro/SSA and La/SSB,) isolated anti-Ro/SSA, isolated anti-La/SSB, and immunonegative. Results. The cohort included 12,084 patients (11,293 females, mean 52.4 years) with recorded ESSDAI scores available. Among them, 279 (2.3%) had isolated anti-La/SSB antibodies. The mean total ESSDAI score at diagnosis of patients with pSS carrying isolated anti-La/SSB was 6.0, and 80.4% of patients had systemic activity (global ESSDAI score >= 1) at diagnosis. The domains with the highest frequency of active patients were the biological (42.8%), glandular (36.8%) and articular (31.2%) domains. Patients with isolated anti-La/ SSB showed a higher frequency of active patients in all ESSDAI domains but two (articular and peripheral nerve) in comparison with immune-negative patients, and even a higher absolute frequency in six clinical ESSDAI domains in comparison with patients with isolated anti-Ro/SSA. In addition, patients with isolated anti-La/SSB showed a higher frequency of active patients in two ESSDAI domains (pulmonary and glandular) with respect to the most active immunological subset (double-positive antibodies). Meanwhile, systemic activity detected in patients with isolated anti-La/SSB was overwhelmingly low. Even in ESSDAI domains where patients with isolated anti-La/SSB had the highest frequencies of systemic activity (lymphadenopathy and muscular), the percentage of patients with moderate or high activity was lower in comparison with the combined Ro/SSA and La/SSB group. Conclusion. Patients carrying isolated La/SSB antibodies represent a very small subset of patients with a systemic SS phenotype characterised by a significant frequency of active patients in most clinical ESSDAI domains but with a relative low frequency of the highest severe organ-specific involvements. Primary SS still remains the best clinical diagnosis for this subset of patients.
- Published
- 2020